Long Noncoding RNA CPS1-IT1 Suppresses Cell Proliferation and Metastasis in Human Lung Cancer.
The long noncoding CPS1 intronic transcript 1 (lncRNA CPS1-IT1) is a recently identified tumor suppressor in the lncRNA family of proteins. Whether this lncRNA plays any functional role in solid tumors remains largely unknown. The present study aimed to investigate the role of lncRNA CPS1-IT1 in human lung cancer. Expression of lncRNA CPS1-IT1 was initially assessed in human lung cancer and in a series of lung cancer cell lines. The effects of CPS1-IT1 overexpression on cell proliferation, migration, and invasion were examined in lung cancer cell lines A549 and 95D. It was found that lncRNA CPS1-IT1 was significantly lower in cancerous tissues than in noncancerous tissues. lncRNA CPS1-IT1 was differentially expressed in lung cancer cell lines and expressed the least in two highly invasive cell lines, A549 and 95D. Overexpression of CPS1-IT1 slowed down cell proliferation by 35.7% in A549 cells and 30.8% in 95D cells on the fifth day. Cell migration was inhibited by 59% in A549 cells and 48% in 95D cells, and cell invasion was suppressed by 60% in both cell lines after overexpression of CPS1-IT1. While cell apoptosis was induced, CPS1-IT1 overexpression promoted the activities of caspase 3 and caspase 9 without affecting that of caspase 8. These observations were suggestive of the tumor-suppressive role of lncRNA CPS1-IT1 in lung cancer. Our data suggest that CPS1-IT1 may be used as a biomarker for early diagnosis and therapeutic targets against lncRNA and may be promising in the treatment of lung cancer.
Zhao
Z
Xiaoguang
Liu
L
Meirong
Zhang
Z
Jingjing
Zhang
Z
Ruishen
Zhang
Z
Qing
Tan
T
Xiaofeng
D000072283:A549 Cells; D017209:Apoptosis / Q000235:genetics; D014408:Biomarkers, Tumor / Q000235:genetics; D020169:Caspases / Q000235:genetics; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000235:genetics; D049109:Cell Proliferation / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology; D009361:Neoplasm Invasiveness / Q000235:genetics; D009362:Neoplasm Metastasis / Q000235:genetics*; D062085:RNA, Long Noncoding / Q000235:genetics*
D014408:Biomarkers, Tumor; D062085:RNA, Long Noncoding; D020169:Caspases
Nat Rev Mol Cell Biol. 2013 Nov;14(11):699-712
24105322
Oncotarget. 2015 Sep 15;6(27):23342-57
26160837
Nat Nanotechnol. 2009 Oct;4(10):669-73
19809459
Nat Rev Genet. 2007 Jun;8(6):413-23
17486121
J Exp Clin Cancer Res. 2015 Jan 22;34:7
25613496
J Hematol Oncol. 2013 May 31;6:37
23725405
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
20610543
Oncogene. 2008 Oct 20;27(48):6194-206
18931687
Tumour Biol. 2015 May;36(5):3355-9
25613066
Mol Cancer. 2011 Apr 13;10:38
21489289
Biochim Biophys Acta. 2012 Mar;1823(3):624-35
21951723
Cancer Res. 2010 Mar 15;70(6):2350-8
20179190
Oncotarget. 2014 Sep 30;5(18):8027-38
25275300
Chest. 2000 Oct;118(4):952-8
11035662
Oncotarget. 2016 Jul 12;7(28):43588-43603
27248828
J Thorac Dis. 2015 Apr;7(Suppl 2):S156-62
25984362
Nucleic Acids Res. 2014 Jul;42(13):8258-70
25013169
J Clin Endocrinol Metab. 2003 Nov;88(11):5119-26
14602737
Cell. 2014 Mar 27;157(1):77-94
24679528
BMC Cancer. 2013 Oct 07;13:461
24098911
CA Cancer J Clin. 2015 Mar;65(2):87-108
25651787
Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R17-29
16651366
Cell. 2011 Mar 18;144(6):926-39
21414484
Clin Cancer Res. 2014 Jan 15;20(2):358-71
24218515